Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,606.49
(
-0.27%
)
US TECH 100
23,763.96
(
-0.13%
)
Dow Jones
46,021.43
(
-0.44%
)
Brent Oil
103.74
(
-0.66%
)
Bitcoin
70,592.63
(
0.99%
)
News Focus
News Focus

Replies to post #84896 on Biotech Values

Replies to #84896 on Biotech Values
icon url

DewDiligence

10/12/09 4:44 PM

#84935 RE: genisi #84896

Perhaps you were thinking of Pharming's recombinant human C1 inhibitor.

No, I wasn’t thinking of Pharming’s Rhucin, which is not directly comparable to Berinert and Cinryze due to its much shorter half-life (#msg-29201262). Rather, I must have been thinking of the statement by Lev’s CEO on one of the company’s earliest CC’s in 2007 that the company intended to develop a recombinant C1 inhibitor.